Related references
Note: Only part of the references are listed.TIR/BB-loop mimetic AS-1 attenuates cardiac ischemia/reperfusion injury via a caveolae and caveolin-3-dependent mechanism
Yuanping Hu et al.
SCIENTIFIC REPORTS (2017)
The Transition From Hypertension to Heart Failure
Franz H. Messerli et al.
JACC-Heart Failure (2017)
Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction
Ward A. Heggermont et al.
CIRCULATION (2017)
The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation
Xiaolu Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
miR-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension (vol 117, pg 870, 2015)
Lin Deng
CIRCULATION RESEARCH (2017)
The TIR/BB-loop mimetic AS-1 attenuates mechanical stress-induced cardiac fibroblast activation and paracrine secretion via modulation of large tumor suppressor kinase 1
Min Fan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy
Lichun Zhou et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2016)
Functions of miRNAs during Mammalian Heart Development
Shun Yan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Left Ventricular Hypertrophy in Valvular Aortic Stenosis: Mechanisms and Clinical Implications
Florian Rader et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Pellino1-mediated TGF-β1 synthesis contributes to mechanical stress induced cardiac fibroblast activation
Juan Song et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Pathological vs. physiological cardiac hypertrophy
Andreas N. Kavazis
JOURNAL OF PHYSIOLOGY-LONDON (2015)
MicroRNA-143/-145 in Cardiovascular Diseases
Wang Zhao et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Loss of MicroRNA-155 Protects the Heart From Pathological Cardiac Hypertrophy
Hee Young Seok et al.
CIRCULATION RESEARCH (2014)
MYOCARDIAL METABOLIC REMODELING IN HYPERTENSION INDUCED LEFT VENTRICULAR HYPERTROPHY
Yasmin S. Hamirani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Signaling effectors underlying pathologic growth and remodeling of the heart
Jop H. van Berlo et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
MICRORNA 143-145 DEFICIENCY IMPAIRS VASCULAR FUNCTION
G. D. Norata et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling
Yun Zhu et al.
BASIC RESEARCH IN CARDIOLOGY (2011)
The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis
Dekker C. Deacon et al.
DEVELOPMENT (2010)
The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease
L. Ella et al.
CELL DEATH AND DIFFERENTIATION (2009)
Reciprocal Regulation of Myocardial microRNAs and Messenger RNA in Human Cardiomyopathy and Reversal of the microRNA Signature by Biomechanical Support
Scot J. Matkovich et al.
CIRCULATION (2009)
MicroRNA Regulation of Cardiovascular Development
Kimberly R. Cordes et al.
CIRCULATION RESEARCH (2009)
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster
Thomas Boettger et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
MicroRNA-133 controls cardiac hypertrophy
Alessandra Care et al.
NATURE MEDICINE (2007)
Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway
Le Yang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
MicroRNAs in cell proliferation, cell death, and tumorigenesis
HW Hwang et al.
BRITISH JOURNAL OF CANCER (2006)
From left ventricular hypertrophy to congestive heart failure: Management of hypertensive heart disease
AH Gradman et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2006)
Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice
A Dikalova et al.
CIRCULATION (2005)
Left ventricular hypertrophy in hypertension: Its arrhythmogenic potential
T Kahan et al.
HEART (2005)
MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression
S Janssens et al.
FEBS LETTERS (2003)
A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses
T Bartfai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mitogen-activated protein kinases:: A new therapeutic target in cardiac pathology
T Ravingerová et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2003)
Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy
DJ Lips et al.
EUROPEAN HEART JOURNAL (2003)
Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice
JK Bendall et al.
CIRCULATION (2002)
Share Paper
